ASHP advocates and supports the professional practice of pharmacists in hospitals, health systems, ambulatory care clinics, and other settings, spanning the full spectrum of medication use. The 2019 meeting was held December 8-12 in Las Vegas, Nevada.
Azurity Pharmaceuticals & Gap Analysis
Shama M. Patel, PharmD, Azurity Pharmaceuticals, Inc.
Demler Describes Importance of Rapid Pathogen Response
Tammie Lee Demler, BS, PharmD, MBA, BCGP, BCPP, clinical pharmacist and director of pharmacy services for a large state hospital, residency program director for the University of Buffalo School of Pharmacy, and U.S. Pharmacist Editorial Board of Advisors member
KOL Hill Highlights Key Antimicrobial Stewardship Strategies
Brandon Hill, PharmD, BCPS, clinical pharmacist in infectious diseases/antimicrobial stewardship, Department of Pharmacy Services, University of Virginia Health System
What you can expect at this year’s conference
ASHP Convening in Las Vegas
Meeting Projected to Draw More Than 25,000 Pharmacists
Attended by pharmacy professionals from more than 100 countries from around the globe, the 2019 American Society of Health-System Pharmacists Midyear Clinical Meeting & Exhibition, which will take place in Las Vegas, Nevada, from December 8-12, provides valuable opportunities for professional development, networking, enhancing practice skills, and staying current with the latest products and innovations. Read More.
New Programs Inform Scientific Innovation
This year’s Midyear Clinical Meeting features new educational programs covering the latest trends in technology. This Tuesday afternoon program will help attendees consider how science will impact pharmacy in the near future and determine ways practitioners might incorporate exciting innovations into their practice. Sessions include Autonomous Delivery: Your Drone Has Arrived! and How Disruptive Innovation Is Changing the Healthcare and Pharmacy Ecosystem. Read More.
Spotlighting Antimicrobial Stewardship
A number of educational sessions at the 2019 ASHP Midyear Clinical Meeting & Exhibition will highlight the antimicrobial stewardship challenges faced by healthcare systems in the United States. Among these, on Sunday, December 8, CDC Medical Epidemiologist Arjun Srinivasan presents the regulatory perspective in CDC Update 2019: Antibiotic Stewardship in America’s Hospitals. Read More.
Meeting Schedule at a Glance
SUNDAY, December 8
8:00 a.m. – 5:00 p.m. Educational Programming
8:30 a.m. – 5:00 p.m. ASHP Well-Being Collaborative
MONDAY, December 9
9:00 a.m. – 10:30 a.m. Opening Session and Keynote
11:00 a.m. – 3:00 p.m. Exhibit Hall Open
2:00 p.m. – 5:15 p.m. Educational Programming
TUESDAY, December 10
8:00 a.m. – 11:00 a.m. Educational Programming
11:00 a.m. – 3:00 p.m. Exhibit Program
Post Conference Wrap
Recapping the 2019 ASHP Midyear Meeting
Surveying the Current State of Biosimilars
On Tuesday, December 10, during the 2019 ASHP Midyear Clinical Meeting & Exhibition in Las Vegas, Nevada, in an educational session titled "The Rise of the Biosimilars: Increasing Use on a Broad Scale," pharmacy professionals from health systems in Colorado and Tennessee assessed the current state of biosimilar medications from the regulatory and clinical perspectives. Read more
Sessions Address Antimicrobial Stewardship
A pair of educational sessions presented by Brandon Hill, PharmD, BCPS, University of Virginia Health System (above right) on Sunday, December 8, 2019, at the 2019 ASHP Midyear Meeting & Exhibition assessed the critical mission of ensuring that hospital-acquired infection rates remain as low as possible, including a tutorial on how to prepare new pharmacists for vital antimicrobial leadership roles and surveying technologies to quickly identify hospital infections. Read more
Poster Points to Superior Stability of Omeprazole Suspension Kit
Remonica Jackson, BS, MS, PharmD candidate, East Tennessee State University (above right), delivered a poster presentation during the 2019 ASHP Midyear Clinical Meeting & Exhibition on Monday, December 9, analyzing the comparative stability of compounded omeprazole suspension versus a commercial omeprazole kit when stored in oral syringes under refrigerated conditions. Read more
FDA Updates Attendees on Compounding Policies
On Tuesday morning during the 2019 ASHP Midyear Clinical Meeting & Exhibition, Tracy Rupp, PharmD, MPH, RD, consumer safety officer, FDA, Silver Spring, Maryland, and Marci Kiester, PharmD, MSHS, RAC, senior policy analyst, FDA, reviewed the FDA's 2019 compounding policy priorities, discussing recent compounding policy documents while reviewing current good manufacturing practice and the agency's proposed policies for compounders registered as outsourcing facilities. Read more